Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis
Academic Article
Publication Date:
2022
abstract:
Pancreatic cancer represents one of the leading causes of cancer-related death worldwide. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), normothermic intraperitoneal chemotherapy (NIPEC), and pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been proven with curative intent mainly for other tumors and there is a lack of consensus regarding possible benefits also in pancreatic cancer. The present systematic review and meta-analysis aim to provide an up-to-date overview of the effectiveness and safety of intraperitoneal treatments in the management of pancreatic cancer.
Iris type:
1.1 Articolo in rivista
Keywords:
Hyperthermic IntraPeritoneal chemotherapy; Intraperitoneal chemotherapy; Meta-analysis; Normothermic IntraPeritoneal chemotherapy; Pancreatic adenocarcinoma; Pancreatic cancer; Pressurized IntraPeritoneal aerosol chemotherapy; Systematic review; Aerosols; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytoreduction Surgical Procedures; Humans; Adenocarcinoma; Hyperthermia, Induced; Pancreatic Neoplasms; Peritoneal Neoplasms
List of contributors:
Frassini, Simone; Calabretto, Francesca; Granieri, Stefano; Fugazzola, Paola; Viganò, Jacopo; Fazzini, Nicola; Ansaloni, Luca; Cobianchi, Lorenzo
Published in: